UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 384

Sortiert nach

Tenofovir-Based Preexposure Prophylaxis for HIV Infection among African Women

The New England journal of medicine, 2015-02, Vol.372 (6), p.509-518

2015

Link zum Volltext

Verfügbarkeit prüfen

Successes and challenges of HIV prevention in men who have sex with men

The Lancet (British edition), 2012-07, Vol.380 (9839), p.388-399

2012

Link zum Volltext

Verfügbarkeit prüfen

Development of HIV-1 rectal-specific microbicides and colonic tissue evaluation

PloS one, 2014-07, Vol.9 (7), p.e102585

2014

Link zum Volltext

Verfügbarkeit prüfen

A topical rectal douche product containing Q-Griffithsin does not disrupt the epithelial border or alter CD4 + cell distribution in the human rectal mucosa

Scientific reports, 2023-05, Vol.13 (1), p.7547-7547, Article 7547

2023

Link zum Volltext

Verfügbarkeit prüfen

A phase 1 randomized, double blind, placebo controlled rectal safety and acceptability study of tenofovir 1% gel (MTN-007)

PloS one, 2013-04, Vol.8 (4), p.e60147

2013

Link zum Volltext

Verfügbarkeit prüfen

An Open-Label Pharmacokinetic and Pharmacodynamic Assessment of Tenofovir Gel and Oral Emtricitabine/Tenofovir Disoproxil Fumarate

AIDS research and human retroviruses, 2022-04, Vol.38 (4), p.279

2022

Link zum Volltext

Verfügbarkeit prüfen

Reverse Transcriptase Inhibitors as Potential Colorectal Microbicides

Antimicrobial Agents and Chemotherapy, 2009-05, Vol.53 (5), p.1797-1807

2009

Link zum Volltext

Verfügbarkeit prüfen

Human Semen or Seminal Plasma Does Not Enhance HIV-1 BaL Ex Vivo Infection of Human Colonic Explants

AIDS research and human retroviruses, 2018-05, Vol.34 (5), p.459

2018

Link zum Volltext

Verfügbarkeit prüfen

A multi-compartment single and multiple dose pharmacokinetic comparison of rectally applied tenofovir 1% gel and oral tenofovir disoproxil fumarate

PloS one, 2014-10, Vol.9 (10), p.e106196

2014

Link zum Volltext

Verfügbarkeit prüfen

Prevention of SIV rectal transmission and priming of T cell responses in macaques after local pre-exposure application of tenofovir gel

PLoS medicine, 2008-08, Vol.5 (8), p.e157; discussion e157-e157

2008

Link zum Volltext

Verfügbarkeit prüfen

The development of rectal microbicides for HIV prevention

Expert opinion on drug delivery, 2014-01, Vol.11 (1), p.69-82

McGowan, Ian

2014

Link zum Volltext

Verfügbarkeit prüfen

Rectal transmission of transmitted/founder HIV-1 is efficiently prevented by topical 1% tenofovir in BLT humanized mice

PloS one, 2013-03, Vol.8 (3), p.e60024-e60024

2013

Link zum Volltext

Verfügbarkeit prüfen

First phase 1 double-blind, placebo-controlled, randomized rectal microbicide trial using UC781 gel with a novel index of ex vivo efficacy

PloS one, 2011-09, Vol.6 (9), p.e23243

2011

Link zum Volltext

Verfügbarkeit prüfen

Protection Against Rectal Chimeric Simian/Human Immunodeficiency Virus Transmission in Macaques by Rectal-Specific Gel Formulations of Maraviroc and Tenofovir

The Journal of infectious diseases, 2015-12, Vol.212 (12), p.1988-1995

2015

Link zum Volltext

Verfügbarkeit prüfen

Correlation between compartmental tenofovir concentrations and an ex vivo rectal biopsy model of tissue infectibility in the RMP-02/MTN-006 phase 1 study

PloS one, 2014-10, Vol.9 (10), p.e111507

2014

Link zum Volltext

Verfügbarkeit prüfen

Rectal Microbicides: Can We Make Them and Will People Use Them?

AIDS and behavior, 2011-04, Vol.15 (Suppl 1), p.66-71

McGowan, Ian

2011

Link zum Volltext

Verfügbarkeit prüfen

Safety and Pharmacokinetics of a Tenofovir Alafenamide Fumarate-Emtricitabine based Oral Antiretroviral Regimen for Prevention of HIV Acquisition in Women: A Randomized Controlled Trial

EClinicalMedicine, 2021-06, Vol.36, p.100893, Article 100893

2021

Link zum Volltext

Verfügbarkeit prüfen

An Overview of Antiretroviral Pre-Exposure Prophylaxis of HIV Infection

American journal of reproductive immunology (1989), 2014-06, Vol.71 (6), p.624-630

McGowan, Ian

2014

Link zum Volltext

Verfügbarkeit prüfen

Phase I/II Trial of the Pharmacokinetics, Safety, and Antiretroviral Activity of Tenofovir Disoproxil Fumarate in Human Immunodeficiency Virus-Infected Adults

Antimicrobial Agents and Chemotherapy, 2001-10, Vol.45 (10), p.2733-2739

2001

Link zum Volltext

Verfügbarkeit prüfen

Project Gel a Randomized Rectal Microbicide Safety and Acceptability Study in Young Men and Transgender Women

PloS one, 2016-06, Vol.11 (6), p.e0158310-e0158310

2016

Link zum Volltext

Verfügbarkeit prüfen

Mucosal effects of tenofovir 1% gel

eLife, 2015-02, Vol.4

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 384

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(311)
Mit Volltextzugriff
(269)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(206)
Life Sciences & Biomedicine
(183)
Humans
(164)
Male
(93)
Female
(91)
Infectious Diseases
(75)
Human Immunodeficiency Virus
(72)
Adult
(71)
Hiv
(69)
Immunology
(63)
Middle Aged
(48)
Hiv Infections - Prevention & Control
(47)
Virology
(37)
Young Adult
(35)
Tenofovir
(34)
Aids/hiv
(31)
Biological And Medical Sciences
(31)
Medicine
(29)
Rectum
(29)
Adolescent
(28)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Tenofovir-Based Preexposure Prophylaxis for HIV Infection among African Women

Successes and challenges of HIV prevention in men who have sex with men

Safety, immunogenicity and effect on viral rebound of HTI vaccines in early treated HIV-1 infection: a randomized, placebo-controlled phase 1 trial

Development of HIV-1 rectal-specific microbicides and colonic tissue evaluation

A topical rectal douche product containing Q-Griffithsin does not disrupt the epithelial border or alter CD4 + cell distribution in the human rectal mucosa

A phase 1 randomized, double blind, placebo controlled rectal safety and acceptability study of tenofovir 1% gel (MTN-007)

An Open-Label Pharmacokinetic and Pharmacodynamic Assessment of Tenofovir Gel and Oral Emtricitabine/Tenofovir Disoproxil Fumarate

Reverse Transcriptase Inhibitors as Potential Colorectal Microbicides

Human Semen or Seminal Plasma Does Not Enhance HIV-1 BaL Ex Vivo Infection of Human Colonic Explants

A multi-compartment single and multiple dose pharmacokinetic comparison of rectally applied tenofovir 1% gel and oral tenofovir disoproxil fumarate

A Phase 1 Randomized, Open Label, Rectal Safety, Acceptability, Pharmacokinetic, and Pharmacodynamic Study of Three Formulations of Tenofovir 1% Gel (the CHARM-01 Study)

Prevention of SIV rectal transmission and priming of T cell responses in macaques after local pre-exposure application of tenofovir gel

The development of rectal microbicides for HIV prevention

Rectal transmission of transmitted/founder HIV-1 is efficiently prevented by topical 1% tenofovir in BLT humanized mice

First phase 1 double-blind, placebo-controlled, randomized rectal microbicide trial using UC781 gel with a novel index of ex vivo efficacy

High levels of adherence to a rectal microbicide gel and to oral Pre-Exposure Prophylaxis (PrEP) achieved in MTN-017 among men who have sex with men (MSM) and transgender women

Protection Against Rectal Chimeric Simian/Human Immunodeficiency Virus Transmission in Macaques by Rectal-Specific Gel Formulations of Maraviroc and Tenofovir

Correlation between compartmental tenofovir concentrations and an ex vivo rectal biopsy model of tissue infectibility in the RMP-02/MTN-006 phase 1 study

Rectal Microbicides: Can We Make Them and Will People Use Them?

Safety and Pharmacokinetics of a Tenofovir Alafenamide Fumarate-Emtricitabine based Oral Antiretroviral Regimen for Prevention of HIV Acquisition in Women: A Randomized Controlled Trial

An Overview of Antiretroviral Pre-Exposure Prophylaxis of HIV Infection

Phase I/II Trial of the Pharmacokinetics, Safety, and Antiretroviral Activity of Tenofovir Disoproxil Fumarate in Human Immunodeficiency Virus-Infected Adults

Long-acting rilpivirine as potential pre-exposure prophylaxis for HIV-1 prevention (the MWRI-01 study): an open-label, phase 1, compartmental, pharmacokinetic and pharmacodynamic assessment

Project Gel a Randomized Rectal Microbicide Safety and Acceptability Study in Young Men and Transgender Women

Mucosal effects of tenofovir 1% gel

Suchergebnisse filtern